Episode: 194 - Douglas Kelly on the Value of Innovation and Breakthrough Designation

This month at Medtech Talk, co-host Justin Klein, co-founder and managing partner at Vensana Capital, debuts in his first episode with a discussion with Douglas Kelly, former deputy center director for science and chief scientist at the Center for Devices and Radiological Health at the FDA. Kelly talks about his time at the FDA and the fundamental changes he implemented to make a helpful impact on patients, including when the pandemic was at its peak. Kelly also shares his thoughts on the value of fostering innovation and the importance of breakthrough designation, as well as how to approach the process of advocacy and get in better alignment with shared priorities with the FDA, CMS, and other stakeholders

You can listen to Episode: 194 - Douglas Kelly on the Value of Innovation and Breakthrough Designation online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode: 194 - Douglas Kelly on the Value of Innovation and Breakthrough Designation is an episode from Medtech Talk by Healthegy.

This episode is 69:32 long.

This episode was published on Mar 27, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Medtech Talk when more episodes are available from the podcast feed.